Medicare Enrolled
Dr. Ranjit Nair, M.D.
Pulmonary Disease · N.Richland Hills, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Nair from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nair?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Nair
Dr. Ranjit Nair is a pulmonary disease specialist in N.Richland Hills, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Nair performed 6,009 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Nair received a total of $105,630 from 58 pharmaceutical and/or device companies across 740 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Nair is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 3% volume in TX
$105,630 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗6,009
Medicare services
Top 3% in TX for pulmonary disease
Not available
Unique patients (not deduplicated)
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Allergy skin test A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens. |
2,952 | $3 | $13 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
575 | $132 | $289 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
515 | $164 | $548 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
439 | $28 | $123 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
417 | $41 | $110 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
412 | $42 | $106 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
256 | $61 | $144 |
| New patient office visit, complex (60-74 min) | 120 | $156 | $413 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function. |
110 | $115 | $358 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
84 | $72 | $339 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
36 | $135 | $405 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
29 | $93 | $215 |
| Lung biopsy via endoscope, 1 lobe A procedure to remove a small sample of lung tissue from one lobe using an endoscope for examination. |
20 | $55 | $844 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
16 | $27 | $634 |
| Endoscopic needle biopsy of windpipe, airway, or lung A procedure where a needle is inserted through an endoscope to collect tissue samples from the windpipe, airway, or lung. |
15 | $136 | $1,007 |
| Bronchoscopy with ultrasound and growth treatment A procedure using a flexible tube with a camera and ultrasound to examine the lung airways and treat any growths found. |
13 | $48 | $219 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$105,630
Total received (2018-2024)
Avg $15,090/year across 7 years
Top 4% in TX for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
740
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$26,868
2023
$24,172
2022
$21,511
2021
$5,630
2020
$5,084
2019
$18,631
2018
$3,733
Payments by company (2024)
JAZZ PHARMACEUTICALS INC.
$9,892
Mylan Specialty L.P.
$6,068
Boehringer Ingelheim Pharmaceuticals, Inc.
$3,887
AstraZeneca Pharmaceuticals LP
$3,639
GlaxoSmithKline, LLC.
$568
Actelion Pharmaceuticals US, Inc.
$373
GENZYME CORPORATION
$299
Regeneron Pharmaceuticals, Inc.
$280
Takeda Pharmaceuticals U.S.A., Inc.
$275
Amgen Inc.
$196
Regeneron Healthcare Solutions, Inc.
$149
Inspire Medical Systems, Inc.
$148
Edwards Lifesciences Corporation
$138
ABIOMED
$114
Ceribell, Inc.
$106
Abbott Laboratories
$95
Vifor Pharma, Inc.
$94
Avadel CNS Pharmaceuticals, LLC
$63
HARMONY BIOSCIENCES LLC
$62
Baxter Healthcare
$52
Grifols USA, LLC
$51
Electromed, Inc.
$47
United Therapeutics Corporation
$43
Itamar Medical Inc
$37
Novartis Pharmaceuticals Corporation
$34
Boston Scientific Corporation
$32
Axsome Therapeutics, Inc.
$30
Optinose US, Inc.
$27
Fisher & Paykel Healthcare Inc
$24
Harmony Biosciences Llc
$17
ZOLL Respicardia, Inc.
$15
Insmed, Inc.
$14
Top 3 companies account for 73.9% of 2024 payments
All-time payments by company (2018-2024) ›
Mylan Specialty L.P.
$30,210
Boehringer Ingelheim Pharmaceuticals, Inc.
$21,888
AstraZeneca Pharmaceuticals LP
$13,164
Intuitive Surgical, Inc.
$10,577
JAZZ PHARMACEUTICALS INC.
$10,327
Incyte Corporation
$3,395
Pinnacle Biologics, Inc
$2,144
GlaxoSmithKline, LLC.
$1,612
GENZYME CORPORATION
$1,065
Edwards Lifesciences Corporation
$918
Regeneron Healthcare Solutions, Inc.
$645
Amgen Inc.
$601
Boston Scientific Corporation
$562
Inspire Medical Systems, Inc.
$528
Genentech USA, Inc.
$513
Harmony Biosciences LLC
$492
Covidien LP
$452
Electromed, Inc.
$433
Olympus Corporation of the Americas
$419
Takeda Pharmaceuticals U.S.A., Inc.
$406
Ethicon Inc.
$400
Sunovion Pharmaceuticals Inc.
$397
Actelion Pharmaceuticals US, Inc.
$373
Baxter Healthcare
$368
Novartis Pharmaceuticals Corporation
$364
Veran Medical Technologies, Inc.
$352
Regeneron Pharmaceuticals, Inc.
$280
United Therapeutics Corporation
$278
Insmed, Inc.
$248
HARMONY BIOSCIENCES LLC
$238
Grifols USA, LLC
$236
ZOLL Respicardia, Inc.
$195
Avadel CNS Pharmaceuticals, LLC
$177
Medivance, Inc.
$173
Advanced Respiratory, Inc
$164
ABIOMED
$114
Ceribell, Inc.
$106
Inogen, Inc.
$100
Abbott Laboratories
$95
Vifor Pharma, Inc.
$94
Axsome Therapeutics, Inc.
$70
Jazz Pharmaceuticals Inc.
$66
Bayer HealthCare Pharmaceuticals Inc.
$44
Genentech, Inc.
$38
Shire North American Group Inc
$37
Itamar Medical Inc
$37
Optinose US, Inc.
$27
EKOS Corporation
$24
Fisher & Paykel Healthcare Inc
$24
Philips Electronics North America Corporation
$24
Shionogi Inc
$22
Tactile Systems Technology Inc
$21
ADVANCED RESPIRATORY, INC
$20
Harmony Biosciences Llc
$17
Merck Sharp & Dohme LLC
$16
Vapotherm Inc
$13
Phadia US Inc.
$13
Merck Sharp & Dohme Corporation
$12
Top 3 companies account for 61.8% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Und · AIRSUPRA · ANORO · ARCTIC SUN · AREXVY · Adempas · Arikayce · BMD Medivance · BREZTRI · BROVANA · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Da Vinci Surgical System · EKOSONIC · EXALT Model D · Esbriet · FASENRA · FISHER & PAYKEL HEALTHCARE · Fetroja · Flexitouch Plus · GLASSIA · General - Pulmonary · HYQVIA · Hillrom - Life 2000 Ventilation System · Hillrom - Monarch Airway Clearance System · Hillrom - Vest System Model 105 Home Care · IMFINZI · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · ION · ImmunoCAP · Impella · LONHALA MAGNAIR · LUMRYZ · Life 2000 Ventilation System · MITRACLIP · Monarch · Monarch Platform · NUCALA · OFEV · OPSUMIT · ORENITRAM · Olympus EBUS Bronchoscopes · POCKET EEG DEVICE · Perforomist · Photofrin · Prolastin-C · Prolastin-C Liquid · Respiratoriy Care Undiv · SAPHNELO · SAPIEN 3 Ultra RESILIA · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Spin · Sunosi · SuperDimension · TAGRISSO · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · The MetaNeb System · UPTRAVI · Utibron · VAPOTHERM · VERQUVO · WAKIX · Wakix · WatchPATONE · XOLAIR · XYREM · XYWAV · Xembify · Xhance · Xolair · YUPELRI · Yupelri · ZERBAXA · Zemaira · remede System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
81
County median income
$81,905
Nearest hospital to ZIP centroid (approximate)
MEDICAL CITY NORTH HILLS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Nair is a mixed practice specialist, with above-average Medicare volume (top 3% in TX), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Nair experienced with allergy skin test?
Based on Medicare claims data, Dr. Nair performed 2,952 allergy skin test services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Nair receive payments from pharmaceutical companies?
Yes. Dr. Nair received a total of $105,630 from 58 companies across 740 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nair's costs compare to other pulmonary diseases in N.Richland Hills?
Dr. Nair's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nair) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in N.Richland Hills
Browse pulmonary diseases in N.Richland Hills ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in TX
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in TX
Which TX pulmonary diseases receive the most from drug and device companies.
By company
Mylan Specialty L.P. Payments to Doctors
See all physicians who received payments from Mylan Specialty L.P.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology